Beibei Zhang

Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer.

Yiping Zhang, Z. Song, Xin-min Yu, 2013, Journal of thoracic disease.

GNAS1基因T393C多态性与EGFR突变状态未明复治晚期非小细胞肺癌TKI疗效的关联研究

W. Mao, Yiping Zhang, B. Lin, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

埃克替尼在晚期非小细胞肺癌EGFR状态明确的患者中的疗效分析

Yiping Zhang, Z. Song, B. Lin, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Docetaxel‐based chemotherapy as second‐line regimen for advanced thymic carcinoma

Yiping Zhang, Z. Song, Xin-min Yu, 2014, Thoracic cancer.

Pretreatment neutrophil‐to‐lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma

Yiping Zhang, Ying Jin, Chunxiao He, 2015, Head & neck.

Efficacy and safety of icotinib in Chinese patients with advanced nonsmall cell lung cancer after failure of chemotherapy

Yiping Zhang, Z. Song, B. Lin, 2014, Chinese medical journal.

Preoperative elevation of serum C‐reactive protein as an indicator of poor prognosis for early‐stage esophageal squamous cell carcinoma

Bo Li, B. Lin, L. Shao, 2013, The Kaohsiung journal of medical sciences.

联合血清肿瘤标志物建立预测厄洛替尼治疗复治非小细胞肺癌生存模型

Yiping Zhang, Z. Song, F. Xie, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.